Funds · XLO

Who owns XLO?

Institutional ownership of Xilio Therapeutics Inc. from Form 13F, Q2 2026

25 institutional managers reported holding Xilio Therapeutics Inc. (XLO) in Form 13F filings for Q2 2026, with 2,756,592 shares worth $26.4M. The largest reported holder was Bain Capital Life Sciences Investors, LLC. Managers that filed both quarters added a net 791,706 shares (+40.3%). 10 opened new positions and 7 sold out.

Funds holding
25
Value held
$26.4M
New / sold out
10 / 7
Net shares, same filers
+40.3%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of XLO

FundValueShare of 13F holdingsSharesMove
Bain Capital Life Sciences Investors, LLC$6.4M24.1%664,021Unchanged
Orbimed Advisors LLC$5.7M21.5%592,300New
Frazier Life Sciences Management, L.P.$4.0M15.3%422,505Unchanged
Stonepine Capital Management, LLC$2.2M8.2%225,994Added
Vanguard Capital Management LLC$1.7M6.5%178,517Added
Sio Capital Management, LLC$1.5M5.5%152,464Unchanged
Adage Capital Partners GP, L.l.c.$1.1M4.0%111,541New
Merck & Co., Inc.$1.0M3.8%105,982Unchanged
Renaissance Technologies LLC$615K2.3%64,153Added
Morgan Stanley$546K2.1%56,954Trimmed
Geode Capital Management, LLC$374K1.4%39,055Added
Citadel Advisors LLC$249K0.9%25,950New
Vanguard Fiduciary Trust Co$216K0.8%22,594Trimmed
Bridgeway Capital Management, LLC$168K0.6%17,544New
Two Sigma Investments, LP$139K0.5%14,544New
Velan Capital Investment Management LP$137K0.5%14,285Unchanged
Gsa Capital Partners LLP$130K0.5%13,590Trimmed
State Street Corp$128K0.5%13,311Unchanged
Prelude Capital Management, LLC$111K0.4%11,600New
BlackRock, Inc.$84K0.3%8,757New
Steward Partners Investment Advisory, LLC$7K0.0%714New
Barclays PLC$1K0.0%115New
Key Financial Inc$5650.0%59Unchanged
Jones Financial Companies LLLP$2620.0%29New
UBS Group AG$1340.0%14Trimmed

Share of 13F holdings is each fund's shares as a share of the 2,756,592 XLO shares all 13F filers reported, not of shares outstanding.

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $9.7M and sold $1.9M; 4 added and 4 trimmed.

Schedule 13D and 13G filings on XLO

Owners of more than 5% must file within days, so these can be newer than the 13F data.

Questions about XLO ownership

Who owns XLO stock?
25 institutional investment managers reported XLO positions in their Form 13F filings for Q2 2026, holding 2,756,592 shares worth $26.4M in total. Bain Capital Life Sciences Investors, LLC reported the largest position.
Are funds buying or selling XLO?
In Q2 2026, 10 managers opened new XLO positions, 4 added, 4 trimmed and 7 sold out. Managers that filed in both quarters added a net 791,706 shares.
How current is this XLO institutional ownership data?
It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to XLO by CUSIP. Options are left out. XLO news and filings · XLO insider trades · Top funds